These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10067677)

  • 1. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses.
    Rajananthanan P; Attard GS; Sheikh NA; Morrow WJ
    Vaccine; 1999 Feb; 17(7-8):715-30. PubMed ID: 10067677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice.
    Rajananthanan P; Attard GS; Sheikh NA; Morrow WJ
    Vaccine; 1999 Aug; 18(1-2):140-52. PubMed ID: 10501244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
    Krishnan L; Dicaire CJ; Patel GB; Sprott GD
    Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG DNA induces stronger immune responses with less toxicity than other adjuvants.
    Weeratna RD; McCluskie MJ; Xu Y; Davis HL
    Vaccine; 2000 Mar; 18(17):1755-62. PubMed ID: 10699323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund's adjuvant.
    Beck L; Spiegelberg HL
    Cell Immunol; 1989 Oct; 123(1):1-8. PubMed ID: 2776217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.
    Oscherwitz J; Hankenson FC; Yu F; Cease KB
    Vaccine; 2006 Apr; 24(15):3018-25. PubMed ID: 16307832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.
    Brewer JM; Conacher M; Satoskar A; Bluethmann H; Alexander J
    Eur J Immunol; 1996 Sep; 26(9):2062-6. PubMed ID: 8814247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
    Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
    J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant modulation of the immune response of mice against the LcrE protein of Chlamydophila pneumoniae.
    Faludi I; Burian K; Csanadi A; Miczak A; Lu X; Kakkar VV; Gonczol E; Endresz V
    Int J Med Microbiol; 2009 Nov; 299(7):520-8. PubMed ID: 19451031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.
    Ben Ahmeida ET; Gregoriadis G; Potter CW; Jennings R
    Vaccine; 1993 Oct; 11(13):1302-9. PubMed ID: 8296483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
    Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
    Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.
    Samo M; Choudhary NR; Riebe KJ; Shterev I; Staats HF; Sempowski GD; Leduc I
    Vaccine; 2016 Feb; 34(9):1193-200. PubMed ID: 26812077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production.
    Fernando GJ; Stenzel DJ; Tindle RW; Merza MS; Morein B; Frazer IH
    Vaccine; 1995; 13(15):1460-7. PubMed ID: 8578827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neither interleukin-6 nor signalling via tumour necrosis factor receptor-1 contribute to the adjuvant activity of Alum and Freund's adjuvant.
    Brewer JM; Conacher M; Gaffney M; Douglas M; Bluethmann H; Alexander J
    Immunology; 1998 Jan; 93(1):41-8. PubMed ID: 9536117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants.
    Stills HF
    ILAR J; 2005; 46(3):280-93. PubMed ID: 15953835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to HIV-1 polytope vaccine candidate formulated in aqueous and alcoholic extracts of Propolis: Comparable immune responses to Alum and Freund adjuvants.
    Mojarab S; Shahbazzadeh D; Moghbeli M; Eshraghi Y; Bagheri KP; Rahimi R; Savoji MA; Mahdavi M
    Microb Pathog; 2020 Mar; 140():103932. PubMed ID: 31857237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune effector cells induced by complete Freund's adjuvant exert an inhibitory effect on antigen-specific type 2 T helper responses.
    Chuang YH; Chiang BL; Chou CC; Hsieh KH
    Clin Exp Allergy; 1997 Mar; 27(3):315-24. PubMed ID: 9088658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the efficacy of liposomes in comparison to new and established adjuvants in potentiating the antibody response against hepatitis B virus surface antigen.
    Tan L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):83-7. PubMed ID: 1807265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants.
    Faquim-Mauro EL; Macedo MS
    Int Immunol; 2000 Dec; 12(12):1733-40. PubMed ID: 11099313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice.
    Babu JP; Pattnaik P; Gupta N; Shrivastava A; Khan M; Rao PV
    Vaccine; 2008 Aug; 26(36):4655-63. PubMed ID: 18640168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.